Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
| ▸ | ARG1 | P05089 | 1/20 | 0.30 |
| ▸ | ARG2 | P78540 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31325798 | 0.74 | ALDH1A1 (0.32) | ALDH1A1TSHRTP53HIF1A | |
| SCHEMBL2374038 | 0.72 | ARG2 (0.35) | ALDH1A1TSHRTP53ARG1ARG2 | |
| Charcoal, Activated SCHEMBL30078180 | 0.69 | TSHR (0.52) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL28515125 | 0.69 | ARG2 (0.34) | ALDH1A1TSHRTP53ARG1ARG2 | |
| SCHEMBL723172 | 0.69 | ALDH1A1 (0.35) | ALDH1A1TSHRTP53CYP2D6CYP2C19 | |
| SCHEMBL176385 | 0.69 | ALDH1A1 (0.35) | ALDH1A1TSHRTP53CYP2D6CYP2C19 | |
| SCHEMBL17818671 | 0.67 | ALDH1A1 (0.33) | ALDH1A1TSHRTP53CYP2D6CYP2C19 | |
| SCHEMBL241764 | 0.67 | ALDH1A1 (0.33) | ALDH1A1TSHRTP53CYP2D6CYP2C19 | |
| SCHEMBL2030122 | 0.67 | — | — | |
| SCHEMBL1701559 | 0.67 | ALDH1A1 (0.39) | ALDH1A1TSHRTP53CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12503543-B2 | Curable photochromic polycarbodiimide compositions | TRANSITIONS OPTICAL, LTD. (IE) | 2025-12-23 | — | — | US | disclosed |
| US-12247168-B2 | Curable photochromic compositions including an oxazoline functional material | TRANSITIONS OPTICAL, LTD. (IE) | 2025-03-11 | — | — | US | disclosed |
| US-20230054095-A1 | Curable Photochromic Polycarbodiimide Compositions | TRANSITIONS OPTICAL, LTD. (IE) | 2023-02-23 | — | — | US | disclosed |
| US-20230059569-A1 | Curable Photochromic Compositions Including an Oxazoline Functional Material | TRANSITIONS OPTICAL, LTD. (IE) | 2023-02-23 | — | — | US | disclosed |
| EP-4081564-A1 | CURABLE PHOTOCHROMIC POLYCARBODIIMIDE COMPOSITIONS | Transitions Optical, Ltd. (IE) | 2022-11-02 | — | — | EP | disclosed |
| EP-4081595-A1 | CURABLE PHOTOCHROMIC COMPOSITIONS INCLUDING AN OXAZOLINE FUNCTIONAL MATERIAL | Transitions Optical, Ltd. (IE) | 2022-11-02 | — | — | EP | disclosed |
| CN-114901717-A | Curable photochromic polycarbodiimide compositions | 光学转变有限公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-114901748-A | Curable photochromic compositions comprising oxazoline-functional materials | 光学转变有限公司 | 2022-08-12 | — | — | CN | disclosed |
| WO-2021129940-A1 | CURABLE PHOTOCHROMIC COMPOSITIONS INCLUDING AN OXAZOLINE FUNCTIONAL MATERIAL | TRANSITIONS OPTICAL, LTD. (IE) | 2021-07-01 | — | — | WO | disclosed |
| WO-2021129939-A1 | CURABLE PHOTOCHROMIC POLYCARBODIIMIDE COMPOSITIONS | TRANSITIONS OPTICAL, LTD. (IE) | 2021-07-01 | — | — | WO | disclosed |
| US-20120048295-A1 | CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2012-03-01 | — | — | US | disclosed |
| US-6365611-B1 | HYDROPHILIC NITRATE VASODILATORS | ISIS PHARMA GMBH (DE) | 2002-04-02 | — | — | US | disclosed |
| EP-1087926-A2 | ANALYTIC SUBSTRATES AND ANTIOXIDATIVE AGENTS | Alpharma-Isis GmbH & Co. KG (DE) | 2001-04-04 | — | — | EP | disclosed |
| US-6180664-B1 | CARDIOVASCUALR DISORDERS; IMPOTENCY | ISIS PHARMA GMBH (DE) | 2001-01-30 | — | — | US | disclosed |
| EP-1009730-A1 | NEW PENTAERYTHRITOL DERIVATIVES, THEIR PRODUCTION AND USE AND INTERMEDIATES FOR THEIR SYNTHESIS | ISIS PHARMA GmbH (DE) | 2000-06-21 | — | — | EP | disclosed |
| EP-0988282-A2 | NOVEL PENTAERYTHRITE DERIVATIVES, THE PRODUCTION AND USE THEREOF AND INTERMEDIATE PRODUCTS FOR THE SYNTHESIS OF THE SAME | ISIS PHARMA GMBH (DE) | 2000-03-29 | — | — | EP | disclosed |
| WO-1999067430-A2 | ANALYTIC SUBSTRATES AND ANTIOXIDATIVE AGENTS | ALPHARMA-ISIS GMBH & CO. KG (DE) | 1999-12-29 | — | — | WO | disclosed |
| CN-1239944-A | New pentaerythritol derivatives, their production, and use and intermdiates for their synthesis | ISIS PHARMA GMBH (DE) | 1999-12-29 | — | — | CN | disclosed |
| WO-1998056759-A2 | NOVEL PENTAERYTHRITE DERIVATIVES, THE PRODUCTION AND USE THEREOF AND INTERMEDIATE PRODUCTS FOR THE SYNTHESIS OF THE SAME | ISIS PHARMA GMBH (DE) | 1998-12-17 | — | — | WO | disclosed |
| WO-1998015521-A1 | NEW PENTAERYTHRITOL DERIVATIVES, THEIR PRODUCTION AND USE AND INTERMEDIATES FOR THEIR SYNTHESIS | ISIS PHARMA GMBH (DE) | 1998-04-16 | — | — | WO | disclosed |